BIOMAT Database Logo BIOMAT Database Logo

Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification. 1991

N Loimer, and L Linzmayer, and J Grünberger
Psychiatrische Klinik, Universität, Vienna, Austria.

The Subjective Opiate Withdrawal Questionnaire (SOWQ) and the Objective Opiate Withdrawal Scale (OOWS) were administered to detect withdrawal distress during a rapid opiate detoxification. No correlations could be observed between the clinical assessments and self ratings of the 20 patients participating in this study. The observers' ratings of withdrawal reached pre-treatment levels within 3 days. In subjective rating, withdrawal distress returned to normal levels 120 h after detoxification. We conclude, that self reports are as important as observer ratings in assessing treatment efficacy. The use of both scales might prevent early relapse after detoxification.

UI MeSH Term Description Entries
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001294 Attitude to Health Public attitudes toward health, disease, and the medical care system. Health Attitude,Attitude, Health,Attitudes, Health,Health Attitudes,Health, Attitude to
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

N Loimer, and L Linzmayer, and J Grünberger
Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts.
January 1985, The American journal of drug and alcohol abuse,
N Loimer, and L Linzmayer, and J Grünberger
Rating depressed patients: observer- vs self-assessment.
May 2000, European psychiatry : the journal of the Association of European Psychiatrists,
N Loimer, and L Linzmayer, and J Grünberger
Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy.
January 1990, Journal of perinatal medicine,
N Loimer, and L Linzmayer, and J Grünberger
Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
January 1989, Journal of psychiatric research,
N Loimer, and L Linzmayer, and J Grünberger
Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
January 1998, Clinical neuropharmacology,
N Loimer, and L Linzmayer, and J Grünberger
Two new rating scales for opiate withdrawal.
January 1987, The American journal of drug and alcohol abuse,
N Loimer, and L Linzmayer, and J Grünberger
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
March 2003, Addiction biology,
N Loimer, and L Linzmayer, and J Grünberger
Effect of ultra-rapid opiate detoxification on withdrawal syndrome.
October 2010, Journal of addictive diseases,
N Loimer, and L Linzmayer, and J Grünberger
Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
January 2008, Pharmacology,
N Loimer, and L Linzmayer, and J Grünberger
Comparison of computerised self-rating scales for depression with conventional observer ratings.
March 1985, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!